Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficit) Equity - Stock Options (Details)

v3.19.3.a.u2
Stockholders' (Deficit) Equity - Stock Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Equity [Abstract]      
Outstanding, Number of Shares, beginning of period (in shares) 2,235,000 15,000  
Granted (in shares) 648,550 2,220,000  
Outstanding, Number of Shares, end of period (in shares) 2,883,550 2,235,000 15,000
Exercisable, Number of Shares (in shares) 867,563    
Outstanding, Weighted Average Exercise Price, beginning of period (in dollars per share) $ 1.74 $ 0.13  
Granted, Weighted Average Exercise Price (in dollars per share) 6.03 1.75  
Outstanding, Weighted Average Exercise Price, end of period (in dollars per share) 2.70 $ 1.74 $ 0.13
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 1.73    
Outstanding, Weighted Average Remaining Life (Year) 8 years 7 months 13 days 9 years 5 months 8 days 9 years 9 months
Exercisable, Weighted Average Remaining Life (Year) 8 years 7 months 28 days    
Outstanding, Aggregate Intrinsic Value $ 23,861,981 $ 23,100 $ 0
Exercisable, Aggregate Intrinsic Value $ 8,025,827